Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 20, Issue SUPPL. 4, 2009, Pages

  Paulussen, M ^a   Bielack, S ^b   Jurgens H ^c   Casali, P G ^d  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Olgahospital ^*  (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD99 ANTIGEN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; LACTATE DEHYDROGENASE; RNA BINDING PROTEIN EWS; TEMOZOLOMIDE; TOPOTECAN; VINCRISTINE;

ARTICLE; BONE MARROW METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 7; COMPUTER ASSISTED TOMOGRAPHY; ETHNICITY; EWING SARCOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

BONE NEOPLASMS; EUROPE; FOLLOW-UP STUDIES; HEALTH PLANNING GUIDELINES; HUMANS; SARCOMA, EWING'S; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 66649094233     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp155     Document Type: Article

References (14)

1. Bacci G, Ferrari S, Bertoni F et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 2000; 18: 4-11.
2. Bernstein ML, Devidas M, Lafreniere D et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457: A report from the Children's Oncology Group. J Clin Oncol 2006; 24: 152-159.
3. Pinkerton CR, Bataillard A, Guillo S et al. Treatment strategies for metastatic Ewing's sarcoma. Eur J Cancer 2001; 37: 1338-1344.
4. Cotterill SJ, Ahrens S, Paulussen M et al. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-3114.
5. Nesbit ME Jr, Gehan EA, Burgert EO et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the first Intergroup study. J Clin Oncol 1990; 8: 1664-1674.
6. Burgert EO Jr, Nesbit ME, Garnsey LA et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup study IESS-II. J Clin Oncol 1990; 8: 1514-1524.
7. Grier HE, Krailo MD, Tarbell NJ et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694-701.
8. Schuck A, Ahrens S, Paulussen M et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003; 55: 168-177.
9. Bacci G, Forni C, Longhi A et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies: 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004; 40: 73-83.
10. Paulussen M, Ahrens S, Craft AW. Ewing's tumors with primary lung metastases. Survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Study patients. J Clin Oncol 1998; 16: 3044-3052.
11. Cangir A, Vietti TJ, Gehan EA et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990; 66: 887-893.
12. EURO-E.W.I.N.G. 99 treatment manual http://euro-ewing.klinikum.unimuenster.de/ (last accessed 18 June 2008).
13. Wagner LM, McAllister N, Goldsby RE et al. Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatr Blood Cancer 2007; 48: 132-139.
14. Bernstein M, Kovar H, Paulussen M et al. Ewing's sarcoma family of tumors: Current management. Oncologist 2006; 11: 503-519.